BRPI0619656A2 - método para isolar um clone de célula única derivada de um cámbio vegetal, clone resultante, método de produção de substáncias vegetais biologicamente ativas e método de preservação de uma linha de célula vegetal - Google Patents
método para isolar um clone de célula única derivada de um cámbio vegetal, clone resultante, método de produção de substáncias vegetais biologicamente ativas e método de preservação de uma linha de célula vegetal Download PDFInfo
- Publication number
- BRPI0619656A2 BRPI0619656A2 BRPI0619656-0A BRPI0619656A BRPI0619656A2 BR PI0619656 A2 BRPI0619656 A2 BR PI0619656A2 BR PI0619656 A BRPI0619656 A BR PI0619656A BR PI0619656 A2 BRPI0619656 A2 BR PI0619656A2
- Authority
- BR
- Brazil
- Prior art keywords
- plant
- cell
- derived
- exchange
- culture
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 45
- 239000000126 substance Substances 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 48
- 239000013543 active substance Substances 0.000 claims abstract description 11
- 238000004321 preservation Methods 0.000 claims abstract description 5
- 230000002062 proliferating effect Effects 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 170
- 241000196324 Embryophyta Species 0.000 claims description 53
- 210000001519 tissue Anatomy 0.000 claims description 31
- 229930012538 Paclitaxel Natural products 0.000 claims description 21
- 229960001592 paclitaxel Drugs 0.000 claims description 21
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 20
- 241001116500 Taxus Species 0.000 claims description 17
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 15
- 238000004114 suspension culture Methods 0.000 claims description 10
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 claims description 9
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 claims description 9
- 230000035945 sensitivity Effects 0.000 claims description 8
- 210000003934 vacuole Anatomy 0.000 claims description 7
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 229930192334 Auxin Natural products 0.000 claims description 5
- 239000002363 auxin Substances 0.000 claims description 5
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000012010 growth Effects 0.000 abstract description 22
- 238000004113 cell culture Methods 0.000 abstract description 18
- 230000007774 longterm Effects 0.000 abstract description 10
- 235000013311 vegetables Nutrition 0.000 abstract description 7
- 230000003247 decreasing effect Effects 0.000 abstract description 3
- 229940088623 biologically active substance Drugs 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 39
- 229930000044 secondary metabolite Natural products 0.000 description 25
- 239000002207 metabolite Substances 0.000 description 22
- 230000002776 aggregation Effects 0.000 description 17
- 238000004220 aggregation Methods 0.000 description 17
- 210000001161 mammalian embryo Anatomy 0.000 description 14
- 238000005138 cryopreservation Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 10
- 230000003750 conditioning effect Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 9
- 210000002421 cell wall Anatomy 0.000 description 8
- 230000006698 induction Effects 0.000 description 8
- 239000005712 elicitor Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 6
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000010412 perfusion Effects 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 239000002211 L-ascorbic acid Substances 0.000 description 4
- 235000000069 L-ascorbic acid Nutrition 0.000 description 4
- 230000032823 cell division Effects 0.000 description 4
- 230000007773 growth pattern Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 244000162450 Taxus cuspidata Species 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940050176 methyl chloride Drugs 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000193986 Kalmia latifolia Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000007614 genetic variation Effects 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 102100039397 Gap junction beta-3 protein Human genes 0.000 description 1
- 101100061841 Homo sapiens GJB3 gene Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000202349 Taxus brevifolia Species 0.000 description 1
- 241001674343 Taxus x media Species 0.000 description 1
- 241001286670 Ulmus x hollandica Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000000063 antileukemic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000008687 biosynthesis inhibition Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 229960002727 cefotaxime sodium Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002338 cryopreservative effect Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000021543 depleted nutrition Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000017095 negative regulation of cell growth Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20050103445 | 2005-10-31 | ||
| KR10-2005-0103445 | 2005-10-31 | ||
| PCT/KR2006/001544 WO2007052876A1 (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through syncronized plant cell cultures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0619656A2 true BRPI0619656A2 (pt) | 2011-10-11 |
| BRPI0619656C1 BRPI0619656C1 (pt) | 2011-12-20 |
Family
ID=38006007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRC10619656-0A BRPI0619656C1 (pt) | 2005-10-31 | 2006-04-25 | método para isolar um clone de célula única derivada de um procámbio vegetal, clone resultante, método de produção de substáncias vegetais biologicamente ativas e método de preservação de uma linha de célula vegetal |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8017397B2 (pt) |
| EP (2) | EP2386626B1 (pt) |
| JP (2) | JP5211296B2 (pt) |
| KR (2) | KR101064519B1 (pt) |
| CN (1) | CN101297028B (pt) |
| AU (1) | AU2006309568B8 (pt) |
| BR (1) | BRPI0619656C1 (pt) |
| CA (1) | CA2627533C (pt) |
| ES (1) | ES2546108T3 (pt) |
| PL (1) | PL1951863T3 (pt) |
| RU (1) | RU2398874C2 (pt) |
| WO (1) | WO2007052876A1 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8053238B2 (en) | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
| EP2386626B1 (en) | 2005-10-31 | 2016-10-26 | Unhwa Corporation | Stability of secondary metabolite mass production through syncronized plant cell cultures |
| KR101064518B1 (ko) * | 2007-09-21 | 2011-09-19 | 주식회사 운화 | 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법 |
| AU2008202078B2 (en) * | 2007-10-10 | 2012-05-31 | Wellkey Holdings Limited | Stability of secondary metabolite mass production through synchronized plant cell cultures |
| KR101100867B1 (ko) * | 2008-05-14 | 2012-01-02 | 주식회사 운화 | 주목의 형성층 또는 전형성층 유래 식물줄기세포주를 유효성분으로 함유하는 항산화, 항염증 또는 항노화용 조성물 |
| RU2500386C2 (ru) | 2008-06-13 | 2013-12-10 | Унхва Корпорейшн | ПРОТИВОВОЗРАСТНАЯ ИЛИ АНТИОКСИДАНТНАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ЛИНИЮ РАСТИТЕЛЬНЫХ СТВОЛОВЫХ КЛЕТОК, ПОЛУЧЕННЫХ ИЗ КАМБИЯ Panax ginseng, ВКЛЮЧАЯ ЖЕНЬШЕНЬ ДИКОГО ТИПА И ЖЕНЬШЕНЬ КОРЕЙСКИЙ |
| KR101179171B1 (ko) * | 2008-08-14 | 2012-09-03 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 |
| BRPI0919298A2 (pt) * | 2008-09-30 | 2019-09-24 | Unhwa Corp | composição para a prevenção ou o tratamento da aids que compreende a linhagem de células do tronco da planta derivada do câmbio da panax ginseng incluindo ginseng selvagem ou ginseng como ingrediente ativo. |
| KR101128953B1 (ko) * | 2008-11-06 | 2012-03-22 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 암의 예방 또는 치료용 조성물 |
| WO2010095911A2 (ko) * | 2009-02-23 | 2010-08-26 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 면역증강용 조성물 |
| WO2010137879A2 (ko) * | 2009-05-26 | 2010-12-02 | 주식회사 운화 | 버드나무과의 형성층 유래 식물줄기세포 및 이의 분리배양방법 |
| KR101212032B1 (ko) * | 2009-05-26 | 2012-12-12 | 주식회사 운화 | 국화과의 형성층 유래 식물줄기세포 및 이의 분리배양방법 |
| EP2436758A2 (en) * | 2009-05-26 | 2012-04-04 | Unhwa Corporation | Plant stem cell derived from cambium of family gingkoaceae and method for the isolation thereof |
| CN102459573A (zh) * | 2009-05-28 | 2012-05-16 | 云火公司 | 茄科的形成层来源的植物干细胞及其分离培养方法 |
| WO2012052854A2 (en) * | 2010-10-23 | 2012-04-26 | Unhwa Corporation | Plant cell lines and methods of isolating the same |
| WO2014133365A1 (ko) | 2013-02-28 | 2014-09-04 | 주식회사 운화 | 재조합 식물세포, 이의 제조방법 및 이를 이용한 목적 단백질의 생산방법 |
| CN103305455A (zh) * | 2013-06-05 | 2013-09-18 | 林树芳 | 红豆杉植物干细胞系培育与抗癌物的提取制作方法 |
| WO2015003178A1 (en) * | 2013-07-03 | 2015-01-08 | Coyne Scientific, Llc | Methods for predicting responses to chemical or biologic substances |
| CN104783324B (zh) * | 2015-03-17 | 2016-08-17 | 湖北中烟工业有限责任公司 | 烟草细胞提取物的制备方法 |
| CN109652360B (zh) * | 2019-01-11 | 2022-04-15 | 成都大学 | 一种获得高生物产量的羌活细胞培养方法 |
| US12022786B2 (en) * | 2019-02-15 | 2024-07-02 | Muhammed Majeed | Method of isolating secondary metabolites from cambium derived callus cultures |
| US11299700B1 (en) | 2021-02-19 | 2022-04-12 | Acequia Biotechnology, Llc | Bioreactor containers and methods of growing hairy roots using the same |
| GB2620405B (en) | 2022-07-06 | 2024-12-04 | Green Bioactives Ltd | Method for isolating plant stem cells from plant leaves and the associated cell lines obtained utilising the method |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1643605A1 (ru) * | 1988-08-15 | 1991-04-23 | Институт Биологии Башкирского Филиала Ан Ссср | Устройство дл выделени изолированных клеток из растительных тканей |
| US5019504A (en) * | 1989-03-23 | 1991-05-28 | The United States Of America As Represented By The Secretary Of Agriculture | Production of taxol or taxol-like compounds in cell culture |
| US5550318A (en) * | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5344775A (en) * | 1991-11-15 | 1994-09-06 | Escagenetics Corporation | Synthesis of taxanes in culture using pseudocalluscells |
| US5407816A (en) | 1992-02-20 | 1995-04-18 | Phyton Catalytic, Inc. | Enhanced production of taxol and taxanes by cell cultures of taxus species |
| US5408816A (en) | 1994-06-27 | 1995-04-25 | Cartier; Lucille L. | Wheeled, hand-propelled carriages for horticultural devices |
| KR970009157A (ko) | 1995-07-08 | 1997-02-24 | 김광호 | 팩시밀리의 송수신에 있어서 문서의 매수지정방법 |
| CN1146488A (zh) * | 1995-09-27 | 1997-04-02 | 中国科学院昆明植物研究所 | 由红豆杉培养细胞生产紫杉醇的工艺 |
| KR100290004B1 (ko) | 1996-01-15 | 2001-05-15 | 허일섭 | 생물반응기에서 주목세포 배양에 의한 탁솔 및 그 유도체의 고수율 생산방법 |
| HUP9901788A3 (en) | 1996-05-24 | 2002-07-29 | Phyton Inc Ithaca | Enhanced production of taxanes by cell cultures of taxus species |
| KR100364478B1 (ko) | 2000-04-04 | 2002-12-16 | 김인숙 | 초음파를 이용한 식물세포의 고농도 배양방법 |
| KR100478213B1 (ko) | 2002-01-23 | 2005-03-22 | 손성호 | 인삼류의 잎과 줄기를 이용한 캘러스 및 부정근 유도와 그증식방법 |
| KR100533120B1 (ko) * | 2003-06-16 | 2005-12-14 | 주식회사 운화 바이오텍 | 형성층을 이용한 식물세포배양 방법 |
| EP2386626B1 (en) | 2005-10-31 | 2016-10-26 | Unhwa Corporation | Stability of secondary metabolite mass production through syncronized plant cell cultures |
| US8053238B2 (en) | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
| KR101068971B1 (ko) | 2007-09-21 | 2011-09-30 | 주식회사 운화 | 분열지연중심부 유래 식물줄기세포주 및 이의 분리방법 |
| KR101064518B1 (ko) | 2007-09-21 | 2011-09-19 | 주식회사 운화 | 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법 |
| AU2008202078B2 (en) | 2007-10-10 | 2012-05-31 | Wellkey Holdings Limited | Stability of secondary metabolite mass production through synchronized plant cell cultures |
| KR101100867B1 (ko) | 2008-05-14 | 2012-01-02 | 주식회사 운화 | 주목의 형성층 또는 전형성층 유래 식물줄기세포주를 유효성분으로 함유하는 항산화, 항염증 또는 항노화용 조성물 |
| RU2500386C2 (ru) | 2008-06-13 | 2013-12-10 | Унхва Корпорейшн | ПРОТИВОВОЗРАСТНАЯ ИЛИ АНТИОКСИДАНТНАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ЛИНИЮ РАСТИТЕЛЬНЫХ СТВОЛОВЫХ КЛЕТОК, ПОЛУЧЕННЫХ ИЗ КАМБИЯ Panax ginseng, ВКЛЮЧАЯ ЖЕНЬШЕНЬ ДИКОГО ТИПА И ЖЕНЬШЕНЬ КОРЕЙСКИЙ |
| KR101179171B1 (ko) | 2008-08-14 | 2012-09-03 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 |
| BRPI0919298A2 (pt) | 2008-09-30 | 2019-09-24 | Unhwa Corp | composição para a prevenção ou o tratamento da aids que compreende a linhagem de células do tronco da planta derivada do câmbio da panax ginseng incluindo ginseng selvagem ou ginseng como ingrediente ativo. |
| WO2010095911A2 (ko) | 2009-02-23 | 2010-08-26 | 주식회사 운화 | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 면역증강용 조성물 |
-
2006
- 2006-04-25 EP EP11174650.9A patent/EP2386626B1/en not_active Expired - Lifetime
- 2006-04-25 US US12/063,929 patent/US8017397B2/en not_active Expired - Lifetime
- 2006-04-25 CA CA2627533A patent/CA2627533C/en not_active Expired - Lifetime
- 2006-04-25 ES ES06757522.5T patent/ES2546108T3/es not_active Expired - Lifetime
- 2006-04-25 BR BRC10619656-0A patent/BRPI0619656C1/pt not_active Application Discontinuation
- 2006-04-25 KR KR1020107029921A patent/KR101064519B1/ko not_active Expired - Lifetime
- 2006-04-25 RU RU2008121914/10A patent/RU2398874C2/ru active
- 2006-04-25 KR KR1020077030252A patent/KR101020689B1/ko not_active Expired - Lifetime
- 2006-04-25 EP EP06757522.5A patent/EP1951863B1/en not_active Expired - Lifetime
- 2006-04-25 WO PCT/KR2006/001544 patent/WO2007052876A1/en not_active Ceased
- 2006-04-25 JP JP2008538791A patent/JP5211296B2/ja not_active Expired - Lifetime
- 2006-04-25 CN CN200680039945.8A patent/CN101297028B/zh not_active Expired - Lifetime
- 2006-04-25 PL PL06757522T patent/PL1951863T3/pl unknown
- 2006-04-25 AU AU2006309568A patent/AU2006309568B8/en not_active Expired
-
2010
- 2010-09-23 US US12/889,026 patent/US20110033903A1/en not_active Abandoned
-
2012
- 2012-10-03 JP JP2012221126A patent/JP6026209B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20080194025A1 (en) | 2008-08-14 |
| WO2007052876A1 (en) | 2007-05-10 |
| CA2627533C (en) | 2015-09-08 |
| AU2006309568B2 (en) | 2012-03-15 |
| KR20110004922A (ko) | 2011-01-14 |
| KR101064519B1 (ko) | 2011-09-19 |
| RU2398874C2 (ru) | 2010-09-10 |
| JP2009513157A (ja) | 2009-04-02 |
| AU2006309568A1 (en) | 2007-05-10 |
| EP2386626A1 (en) | 2011-11-16 |
| JP5211296B2 (ja) | 2013-06-12 |
| EP2386626B1 (en) | 2016-10-26 |
| EP1951863B1 (en) | 2015-07-08 |
| CN101297028A (zh) | 2008-10-29 |
| KR20080029971A (ko) | 2008-04-03 |
| US20110033903A1 (en) | 2011-02-10 |
| CA2627533A1 (en) | 2007-05-10 |
| BRPI0619656C1 (pt) | 2011-12-20 |
| JP6026209B2 (ja) | 2016-11-16 |
| EP1951863A1 (en) | 2008-08-06 |
| KR101020689B1 (ko) | 2011-03-11 |
| EP1951863A4 (en) | 2009-05-20 |
| PL1951863T3 (pl) | 2015-12-31 |
| RU2008121914A (ru) | 2009-12-10 |
| AU2006309568B8 (en) | 2012-04-05 |
| CN101297028B (zh) | 2016-01-20 |
| ES2546108T3 (es) | 2015-09-18 |
| US8017397B2 (en) | 2011-09-13 |
| JP2013031451A (ja) | 2013-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8053238B2 (en) | Isolated population of plant single cells and method of preparing the same | |
| AU2008202078B2 (en) | Stability of secondary metabolite mass production through synchronized plant cell cultures | |
| BRPI0619656A2 (pt) | método para isolar um clone de célula única derivada de um cámbio vegetal, clone resultante, método de produção de substáncias vegetais biologicamente ativas e método de preservação de uma linha de célula vegetal | |
| KR101064518B1 (ko) | 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법 | |
| US20100255585A1 (en) | Plant stem cell line derived from quiescent center and method for isolating the same | |
| JPH03262488A (ja) | ポドフィロトキシン類化合物の製造法 | |
| CA2630150A1 (en) | Plant secondary metabolite production through syncronized procambium cell culture | |
| RU2718253C1 (ru) | Способ получения каллусной культуры змееголовника дланевидного (Dracocephalum palmatum Steph.) в условиях in vitro | |
| KR100775080B1 (ko) | 노랑무늬붓꽃의 생장점 배양을 통한 체세포배 형성과식물체 대량생산방법 | |
| CN108782239A (zh) | 一种银杏脱毒组织培养方法 | |
| RU2374834C1 (ru) | Способ получения растений рапса in vitro | |
| KR20110003887A (ko) | 배추속의 형성층 또는 전형성층 유래 식물줄기세포 및 이의 분리방법 | |
| CN121271777A (zh) | 一种丹参根形成层干细胞的分离分化培养方法 | |
| Menéndez et al. | From Spore to Sporophyte: How to Proceed | |
| UA134132U (uk) | Спосіб отримання амфідиплоїдного гібриду коноплі та хмелю "canhum" | |
| JPH03143396A (ja) | ポドフィロトキシン類化合物の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
| B25C | Requirement related to requested transfer of rights |
Owner name: UNHWA (KR) Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 018110005007/SP DE 11/02/2011, E NECESSARIO APRESENTAR O DOCUMENTO DE CESSAO DEVIDAMENTE NOTARIZADO E COM A LEGALIZACAO CONSULAR, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. Owner name: UNHWA (KR) Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 018110005006/SP DE 11/02/2011, E NECESSARIO APRESENTAR O DOCUMENTO DE CESSAO DEVIDAMENTE NOTARIZADO E COM A LEGALIZACAO CONSULAR, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08J | Incorrect entry in the gazette republished [chapter 8.10 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. TEXTO CORRETO: REFERENTE A 3O ANUIDADE. |
|
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AOS DESPACHOS 8.6 E 8.10 PUBLICADOS NAS RPIS 2161 E 2164 DE 05/06/2012 E 26/06/2012. |
|
| B25B | Requested transfer of rights rejected |
Owner name: UNHWA (KR) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO NO 18110005007/SP DE 11/02/2011, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 2139 DE 03/01/2012. |
|
| B25B | Requested transfer of rights rejected |
Owner name: UNHWA (KR) Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 018110005007/SP DE 11/02/2011, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2139, DE 03/01/2012. |
|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: UNHWA (KR) Free format text: A FIM DE ATENDER AS ALTERACOES DE NOME E ENDERECO REQUERIDAS ATRAVES DA PETICAO NO 018120012068/SP DE 11/04/2012, E NECESSARIO APRESENTAR O DOCUMENTO COM A DEVIDA LEGALIZACAO CONSULAR, A TAXA RELATIVA AO SEGUNDO SERVICO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: UNHWA (KR) Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: A FIM DE ATENDER AS ALTERACOES DE NOME E ENDERECO REQUERIDAS ATRAVES DA PETICAO NO 18120012067/SP DE 11/04/2012, E NECESSARIO APRESENTAR O DOCUMENTO COM A DEVIDA LEGALIZACAO CONSULAR, A TAXA RELATIVA AO SEGUNDO SERVICO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25E | Requested change of name of applicant rejected |
Owner name: UNHWA (KR) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 18120012068/SP DE 11/04/2012, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2182, DE 30/10/2012. Owner name: UNHWA (KR) Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 18120012067/SP DE 11/04/2012, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2183, DE 06/11/2012. |
|
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: WELLKEY HOLDINGS LIMITED (VG) Owner name: WELLKEY HOLDINGS LIMITED (VG) Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
| B11Q | Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |